Skip to main content
VivoSim Labs, INC. logo

VivoSim Labs, INC. — Investor Relations & Filings

Ticker · VIVS ISIN · US68620A2033 US Professional, scientific and technical activities
Filings indexed 790 across all filing types
Latest filing 2015-08-10 Interim / Quarterly Rep…
Country US United States of America
Listing US VIVS

About VivoSim Labs, INC.

https://organovo.com/

VivoSim Labs, Inc. is a biotechnology services company that develops and utilizes bioprinted, three-dimensional (3D) human tissues designed to emulate human biology and disease. The company provides testing services for drugs and drug candidates, primarily for the pharmaceutical and biotechnology sectors. VivoSim Labs specializes in offering liver and intestinal toxicology insights through its proprietary New Approach Methodologies (NAMs), including its NAMkind™ 3D models. These non-animal testing platforms are used to generate human-relevant safety and toxicology data early in the drug discovery and development process, aiming to provide insights before animal studies or clinical trials.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q1 2016
2015-08-10 English
Regulatory Filings 2015
Regulatory Filings
2015-08-05 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, which is a Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934. It includes information about the upcoming Annual Meeting, proposals to be voted on, director nominations, and other shareholder meeting materials. The text explicitly mentions it is a Proxy Statement and includes details typical of proxy materials such as voting instructions and meeting agenda. This matches the definition of Proxy Solicitation & Information Statement (PSI). The document length is under 5,000 characters, but it contains substantive proxy material, not just an announcement of availability, so it is not a Report Publication Announcement (RPA). Therefore, the correct classification is PSI with high confidence.
2015-07-10 English
DEF 14A
Proxy Solicitation & Information Statement
2015-07-10 English
FORM 5 SUBMISSION
Director's Dealing
2015-07-10 English
FORM 5 SUBMISSION
Director's Dealing
2015-07-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.